POI

Clinical trials for POI explained in plain language.

Never miss a new study

Get alerted when new POI trials appear

Sign up with your email to follow new studies for POI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

First human test of experimental treatment for early menopause

Disease control Not yet recruiting

This early-stage study will test the safety of an experimental treatment called YB-1113 for women with premature ovarian insufficiency (early menopause). Six women aged 18-40 will receive the treatment through an IV infusion. Researchers will monitor for side effects and measure …

Matched conditions: POI

Phase: PHASE1 • Sponsor: Bright Cell, Inc. • Aim: Disease control

Last updated Feb 27, 2026 15:19 UTC

POI

Get alerted when new POI trials appear

First human test of experimental treatment for early menopause